The American Urological Association (AUA) provides clinical guidelines for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome (IC/BPS), last updated in 2022 (a PDF copy is available here). These guidelines not only provide a suggested diagnostic process but also categorize treatment options and note the evidence for each.

The current scientific consensus also acknowledges that while some treatment approaches may be helpful for anyone with IC/BPS, there are some that may be more effective in those with a bladder-centric phenotype. Importantly, many IC/BPS patients find relief through a multimodal approach (i.e., using multiple treatment strategies). Patients may also benefit by working with an interdisciplinary team of providers that includes urologists, urogynecologists, gynecologists, pain management specialists, primary care providers, pelvic floor physical therapists, pharmacists, and mental health providers.

Behavioral & Nonpharmacological Treatments

These include pain science education, self-care practices, and pelvic floor physical therapy.

Oral Medications

Various oral therapies may reduce symptoms and address inflammatory responses that worsen symptoms for patients.

Bladder Instillations

These include medications that can be instilled directly into the bladder.

Procedures

There are a number of medical procedures used to treat IC/BPS, with varying degrees of effectiveness.

Major Surgery

Surgery is considered a last resort in the treatment of IC/BPS, but may be considered in patients with severe bladder-centric disease.

Treatments Not Recommended

Over time, the scientific and medical communities have identified treatments that should no longer be used in IC/BPS patients.

Email Sign-Up

Email Sign-Up

Sign up here to receive timely and relevant email communication from the ICA, like our monthly newsletter, research digest, and important announcements for the IC/BPS community!

Name(Required)

Corporate Partners

Desert Harvest logo
Prelief logo